tradingkey.logo

GoodRx Holdings Inc

GDRX
4.290USD
+0.250+6.19%
Close 09/29, 16:00ETQuotes delayed by 15 min
1.51BMarket Cap
43.74P/E TTM

GoodRx Holdings Inc

4.290
+0.250+6.19%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of GoodRx Holdings Inc

Currency: USD Updated: 2025-09-29

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

GoodRx Holdings Inc's Score

Industry at a Glance

Industry Ranking
60 / 469
Overall Ranking
116 / 4714
Industry
Software & IT Services

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 15 analysts
Buy
Current Rating
5.319
Target Price
+31.66%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

GoodRx Holdings Inc Highlights

StrengthsRisks
GoodRx Holdings, Inc. provides a consumer-focused digital healthcare platform in the United States. It offer consumers free access to transparent and lower prices for generic and brand medications, as well as comprehensive healthcare research and information. It also equips healthcare professionals to find and prescribe affordable medications. It offers information and tools to help consumers compare prices and save on their prescription drug purchases. It operates a price comparison platform that provides consumers with geographically relevant prescription pricing and provides access to negotiated prices through its codes that can be used to save money on prescriptions across the United States (the prescription transactions offering). It also offers other healthcare products and services, including pharmaceutical manufacturer solutions, subscriptions, and telehealth services. Its subscription offerings provide additional benefits to consumers of its prescription transactions offering.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Undervalued
The company’s latest PE is 46.26, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 76.10M shares, decreasing 25.55% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 423.00 shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 2.75.

Financial Health

Currency: USD Updated: 2025-09-29

The company's current financial score is 8.73, which is higher than the Software & IT Services industry's average of 7.31. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 203.07M, representing a year-over-year increase of 1.23%, while its net profit experienced a year-over-year increase of 91.86%.

Score

Industry at a Glance

Previous score
8.73
Change
0

Financials

7.50

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data

Quality of Earnings

10.00

Operational Efficiency

10.00

Growth Potential

8.62

Shareholder Returns

7.54

GoodRx Holdings Inc's Company Valuation

Currency: USD Updated: 2025-09-29

The company’s current valuation score is 8.41, which is higher than the Software & IT Services industry's average of 7.21. Its current P/E ratio is 46.26, which is 47.64% below the recent high of 68.30 and 19.11% above the recent low of 37.42.

Score

Industry at a Glance

Previous score
8.41
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 60/469
No Data

Earnings Forecast

Currency: USD Updated: 2025-09-29

The company’s current earnings forecast score is 7.25, which is lower than the Software & IT Services industry's average of 7.60. The average price target for GoodRx Holdings Inc is 5.00, with a high of 7.00 and a low of 3.40.

Score

Industry at a Glance

Previous score
7.25
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 15 analysts
Buy
Current Rating
5.319
Target Price
+31.66%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

112
Total
7
Median
13
Average
Company name
Ratings
Analysts
GoodRx Holdings Inc
GDRX
15
Meta Platforms Inc
META
70
Alphabet Inc
GOOGL
64
Uber Technologies Inc
UBER
55
Netflix Inc
NFLX
50
Shopify Inc
SHOP
50
1
2
3
...
23

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-29

The company’s current price momentum score is 8.30, which is higher than the Software & IT Services industry's average of 7.05. Sideways: Currently, the stock price is trading between the resistance level at 4.48 and the support level at 3.98, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.38
Change
1.92

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(1)
Neutral(3)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
0.017
Neutral
RSI(14)
53.790
Neutral
STOCH(KDJ)(9,3,3)
58.133
Buy
ATR(14)
0.176
High Vlolatility
CCI(14)
75.065
Neutral
Williams %R
12.000
Overbought
TRIX(12,20)
-0.221
Sell
StochRSI(14)
100.000
Buy
Moving Average
Sell(3)
Neutral(0)
Buy(3)
Indicators
Value
Direction
MA5
4.058
Buy
MA10
4.105
Buy
MA20
4.139
Buy
MA50
4.291
Sell
MA100
4.344
Sell
MA200
4.484
Sell

Institutional Confidence

Currency: USD Updated: 2025-09-29

The company’s current institutional recognition score is 7.00, which is higher than the Software & IT Services industry's average of 6.80. The latest institutional shareholding proportion is 77.19%, representing a quarter-over-quarter increase of 2.41%. The largest institutional shareholder is The Vanguard, holding a total of 8.55M shares, representing 8.67% of shares outstanding, with 8.13% increase in holdings.

Score

Industry at a Glance

Previous score
7.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
The Vanguard Group, Inc.
Star Investors
8.61M
+3.01%
Hirsch (Douglas Joseph)
5.47M
+1.05%
Bezdek (Trevor)
5.39M
--
Columbia Threadneedle Investments (US)
4.63M
-3.58%
Lakewood Capital Management, LP
4.89M
--
Renaissance Technologies LLC
Star Investors
3.01M
+4.51%
Silver Lake Partners
3.53M
--
Perot Investments
3.17M
+7.35%
Dimensional Fund Advisors, L.P.
2.29M
+15.13%
Connor, Clark & Lunn Investment Management Ltd.
1.43M
+16.75%
1
2

Risk Assessment

Currency: USD Updated: 2025-09-29

The company’s current risk assessment score is 3.95, which is lower than the Software & IT Services industry's average of 5.03. The company's beta value is 1.23. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.

Score

Industry at a Glance

Previous score
3.95
Change
0
Beta vs S&P 500 index
1.23
VaR
+6.17%
240-Day Maximum Drawdown
+50.14%
240-Day Volatility
+62.22%

Return

Best Daily Return
60 days
+37.27%
120 days
+37.27%
5 years
+37.27%
Worst Daily Return
60 days
-20.05%
120 days
-20.05%
5 years
-38.91%
Sharpe Ratio
60 days
-0.24
120 days
+0.49
5 years
-0.30

Risk Assessment

Maximum Drawdown
240 days
+50.14%
3 years
+62.45%
5 years
+93.91%
Return-to-Drawdown Ratio
240 days
-0.75
3 years
-0.13
5 years
-0.19
Skewness
240 days
+2.06
3 years
+1.72
5 years
+0.36

Volatility

Realised Volatility
240 days
+62.22%
5 years
+72.39%
Standardised True Range
240 days
+5.43%
5 years
+19.77%
Downside Risk-Adjusted Return
120 days
+75.99%
240 days
+75.99%
Maximum Daily Upside Volatility
60 days
+95.54%
Maximum Daily Downside Volatility
60 days
+73.29%

Liquidity

Average Turnover Rate
60 days
+0.82%
120 days
+0.61%
5 years
--
Turnover Deviation
20 days
+275.38%
60 days
+90.86%
120 days
+41.69%

Peer Comparison

Software & IT Services
GoodRx Holdings Inc
GoodRx Holdings Inc
GDRX
7.65 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Adeia Inc
Adeia Inc
ADEA
8.64 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Information Services Group Inc
Information Services Group Inc
III
8.62 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Karooooo Ltd
Karooooo Ltd
KARO
8.56 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cellebrite DI Ltd
Cellebrite DI Ltd
CLBT
8.56 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
VeriSign, Inc
VeriSign, Inc
VRSN
8.53 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI